Results of the JPMA Survey #3 on Status of Implementation of Cardiovascular Toxicity Studies for Drug Discovery (Anticancer pharmaceuticals, Biopharmaceuticals/Vaccines)

  • YAMAMOTO Wataru
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • UTSUMI Yuichi
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • MOTOKAWA Yoshiyuki
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • OKAI Yoshiko
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • KUBO Taeko
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • TANIKAWA Yoichi
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • NAKAJIMA Kenji
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • SAWABE Toshihiro
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • YAMASAKI Nao
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • MORIMOTO Nobutaka
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • TARUI Takeshi
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • ABE Tomoyuki
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • IWASE Yumiko
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA
  • WATANABE Kazuto
    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, JPMA

Bibliographic Information

Other Title
  • 創薬研究における心毒性評価の実施状況に関するアンケート調査(製薬協 基礎研究部会)の結果報告3(抗がん剤,バイオ医薬品・ワクチン)

Description

<p>[in Japanese] </p>

Journal

Details 詳細情報について

  • CRID
    1390845712986423168
  • NII Article ID
    130007432703
  • DOI
    10.14869/toxpt.45.1.0_p-143
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top